Non-Invasive Cancer Testing
The IvyGene test is a blood test that uses advanced DNA sequencing methods to detect the DNA methylation pattern of circulating tumor DNA (ctDNA) in blood samples in order to both confirm the presence of cancer and give quantitative data.
The IvyGene® Score reflects the relative amount of cell-free DNA that contains these methylation markers as a percentage of the total cell-free DNA present. The IvyGene®score is derived from a composite average of methylated vs unmethylated cell-free DNA of specific target sites.
The IvyGene® test has been validated with four (4) cancer tissues of origin: breast, colon, liver and lung cancers. The presence of other cancer types may also result in an elevated IvyGene® Score.
Stop by and visit our booth at our upcoming conferences.
Molecular Med Tri-ConFebruary 11-16, 2018 – San Francisco, CA
American Association for Cancer Research (AACR)April 14-18, 2018 – Chicago, Illinois
- Age Management Medicine Group (AMMG)
November 2-5, 2017 – Tucson, Arizona
A4MDecember 14-16, 2017 – Las Vegas, NV